Literature DB >> 19641471

Retinoblastoma: the challenges of management in Ibadan, Nigeria.

Charles O Bekibele1, Adejumoke I Ayede, Olumide O Asaolu, Biobele J Brown.   

Abstract

BACKGROUND: Retinoblastoma is a common highly malignant tumor of the eye. Late presentation leads to poor survival rate in many developing countries.
OBJECTIVE: To identify problems associated with management of retinoblastoma.
METHODS: A retrospective review of cases of retinoblastoma at the University College Hospital, Ibadan, between January 1992 and December 2007.
RESULTS: A total of 32 eyes of 26 patients were studied. Sixteen were males and 10 were females. Minimum age at presentation was 4 months and maximum age was 60 months (mean 30.69+/-14.2 mo). Over 90% presented after 1 month of onset. Reasons for late diagnosis included late presentation for unknown reasons, missed diagnosis, and mismanagement in a previous hospital. Eleven of 26 patients defaulted to avoid removal of the eye, and treatment was only completed in 5 patients. Problems included financial constraint regarding investigations and procurement of drugs, as well as availability of the chemotherapy.
CONCLUSIONS: Retinoblastoma is a problematic malignancy of childhood associated with management problems often related to difficulty with patients accepting removal of the affected eye and financial constraint for treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19641471     DOI: 10.1097/MPH.0b013e31819c5275

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  11 in total

1.  Preserving vision in retinoblastoma through early detection and intervention.

Authors:  Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  "Retinoblastoma survival disparity": The expanding horizon in developing countries.

Authors:  Masood Naseripour
Journal:  Saudi J Ophthalmol       Date:  2012-02-18

3.  Retinoblastoma in the democratic republic of congo: 20-year review from a tertiary hospital in kinshasa.

Authors:  Aimé Kazadi Lukusa; Michel Ntetani Aloni; Bertin Kadima-Tshimanga; Moïse Mvitu-Muaka; Jean Lambert Gini Ehungu; René Ngiyulu; Pépé Ekulu Mfutu; Aléine Budiongo Nzazi
Journal:  J Cancer Epidemiol       Date:  2012-04-26

4.  Non-glaucomatous optic neuropathy in ibadan: extrapolations to healthcare funding in Nigeria.

Authors:  O A Ogun; O A Adediran
Journal:  Ann Ib Postgrad Med       Date:  2014-12

5.  Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis.

Authors:  Huimin Hu; Weiling Zhang; Yizhuo Wang; Dongsheng Huang; Jitong Shi; Bin Li; Yi Zhang; Yan Zhou
Journal:  BMC Ophthalmol       Date:  2018-04-23       Impact factor: 2.209

6.  Retinoblastoma: A retrospective analysis of 141 patients from 1983 to 2013 at a tertiary care hospital in Nagpur, India.

Authors:  Rohit S Kabre; Krishna M Kamble
Journal:  South Asian J Cancer       Date:  2019 Jul-Sep

7.  Determinants of delayed diagnosis among pediatric cancer patients from Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia.

Authors:  Alemseged Berhane; Tadele Hailu; Afework Mulugeta
Journal:  BMC Pediatr       Date:  2019-12-06       Impact factor: 2.125

8.  A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa.

Authors:  Saadiah Goolam; Hemant Kana; Nicky Welsh; Linda Wainwright; Janet Poole; Ismail Mayet
Journal:  Ocul Oncol Pathol       Date:  2017-11-04

9.  Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes.

Authors:  Meaghann S Weaver; Christina L Heminger; Catherine G Lam
Journal:  BMC Public Health       Date:  2014-09-11       Impact factor: 3.295

10.  Funding paediatric surgery procedures in sub-Saharan Africa.

Authors:  Sebastian O Ekenze; Chukwunonso A Jac-Okereke; Elochukwu P Nwankwo
Journal:  Malawi Med J       Date:  2019-09       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.